David Cohn, MD
David Cohn, MD, professor and director of the Division of Gynecologic Oncology at Ohio State, is the chief medical officer at the James Cancer Hospital and Solove Research Institute.
Dr. Cohn is an internationally renowned gynecologic oncologist and a member of the OSUCCC Translational Therapeutics Program. He holds leadership positions in the Society of Gynecologic Oncology as secretary-treasurer, in NRG Oncology as chair of the Cancer Care Delivery Research Committee, and at the OSUCCC – James as the immediate past chair of the Clinical Scientific Review Committee.
His research focuses on identifying biomarkers for early detection and prevention of ovarian cancer, and on the genetics of endometrial cancer. In addition, Dr. Cohn co-leads the Ohio Prevention and Treatment of Endometrial Cancer (OPTEC) Statewide Initiative launched by the OSUCCC – James.
Dr. Cohn joined Ohio State’s College of Medicine faculty in 2001 and became director of the Division of Gynecologic Oncology in 2011. He earned his MD from Georgetown University Medical School, served his residency in obstetrics and gynecology at the University of Washington Medical Center in Seattle, and completed his fellowship in gynecologic oncology at Washington University in St. Louis.